Cologne, Germany

Mats Paulsson


Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 103(Granted Patents)


Location History:

  • 50931 Cologne, DE (2010)
  • Cologne, DE (1997 - 2014)

Company Filing History:


Years Active: 1997-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Mats Paulsson in Tumor Treatment

Introduction

Mats Paulsson is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of medical technology, particularly in the treatment of tumors and their metastases. With a total of 5 patents, his work focuses on innovative therapeutic methods that target specific biological markers.

Latest Patents

Mats Paulsson's latest patents include a method for treating tumors and their metastases. This invention relates to a therapy designed for tumors that preferentially settle in bone tissue. The method involves administering an active ingredient that comprises at least one binding molecule that binds to human bone sialoprotein or a fragment thereof. Another significant patent is a medicament for treating tumors and their metastases, which also targets bone tissue. This medicament includes at least one binding molecule that binds to bone sialoprotein or a fragment thereof found in serum or plasma.

Career Highlights

Throughout his career, Mats Paulsson has worked with Armbruster Biotechnology GmbH, where he has contributed to various innovative projects. His expertise in the field of biotechnology has allowed him to develop groundbreaking methods for cancer treatment.

Collaborations

Mats has collaborated with notable individuals such as Franz Paul Armbruster and Markus Karmatschek. These partnerships have played a crucial role in advancing his research and patent developments.

Conclusion

Mats Paulsson's contributions to the field of tumor treatment through his innovative patents highlight his dedication to improving medical therapies. His work continues to influence the landscape of cancer treatment and offers hope for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…